header-backissues

Ensuring quality of services in HIV-prevention research settings: findings from a multi-center quality improvement pilot in East Africa

Study Status:
Completed
Countries:
Uganda;Kenya
Population:
Volunteers at 3 IAVI-sponsored research centers in Kenya & Uganda
Participants:
426

 
Study Summary:
 
Quality Improvement (QI) has been widely implemented in health services but has not been widely applied in HIV prevention research. Most prevention research centers have commonly employed traditional approaches (e.g. checklists) to quality control that document what has been done but not the quality of what has been done. Unlike other health settings, prevention research settings have unique characteristics and ethical requirements that require the development or adaptation of specific quality indicators. A QI model for health services was adapted for use in prevention research settings and piloted at 3 research centers in East Africa. On average, 52% of total enrolled volunteers participated in the exit interview. The designed QI plans successfully helped reduce volunteers’ reported waiting time to see counselors and pharmacists. It also increased the percentage of interviewed volunteers who reported being counseled on family planning at clinical trials (from 66% to 93%) at follow-up visits, and who were refreshed on informed consent at follow-up visits (from 90% to 96%). The percentage of interviewed volunteers that expressed satisfaction with services received from counselors increased (from 87% to 94%) while the percentage of volunteer satisfied with services from trial physicians remained constant (93%). The majority of volunteers interviewed reported satisfaction with other major components of research such as confidentiality, understanding of trial objectives, benefits and risks of participation and risk reduction counseling. However, satisfaction with services from community outreach workers and other staff at research centers dropped over the course of the study (from 88% in cycle 1 to 74% in cycle 3). See article published in AIDS Care http://www.tandfonline.com/doi/abs/10.1080/09540120903012569